SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q1 2024
Institutional positions in SAB Biotherapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −18 vs. Q4 2023
- Shares held
- 3.34M
- −219.3K (−6.2%) vs. Q4 2023Converted for a 1-for-10 split
- Total value
- $15.2M
- −$9.32M (−38.1%) vs. Q4 2023
- New holders
- 3
- 6 more added
- Sold out
- 21
- 6 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RTW Investments, LP | 917,827 | $4.17M | 0.06% | 00.0% | UnchangedConverted for a 1-for-10 split |
| BVF Inc | 917,826 | $4.17M | 0.11% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Marshall Wace, LLP | 459,168 | $2.08M | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Sessa Capital IM, L.P. | 458,457 | $2.08M | 0.08% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Commodore Capital LP | 183,174 | $831.6K | 0.06% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Vanguard Group Inc | 176,334 | $800.6K | 0.00% | +76,721+77.0% | AddedConverted for a 1-for-10 split |
| Geode Capital Management, LLC | 63,466 | $288.2K | 0.00% | +27,830+78.1% | AddedConverted for a 1-for-10 split |
| Millennium Management LLC | 54,050 | $245.4K | 0.00% | +54,050 | New |
| Pathstone Holdings, LLC | 50,650 | $230.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| First Manhattan Co | 24,577 | $111.6K | 0.00% | −3,201−11.5% | ReducedConverted for a 1-for-10 split |
| Institutional & Family Asset Management, LLC | 19,201 | $87.2K | 0.01% | 00.0% | UnchangedConverted for a 1-for-10 split |
| BlackRock Inc. | 6,339 | $28.8K | 0.00% | +1,075+20.4% | AddedConverted for a 1-for-10 split |
| Advisor Group Holdings, Inc. | 4,524 | $20.5K | 0.00% | −113−2.4% | ReducedConverted for a 1-for-10 split |
| Tower Research Capital LLC (TRC) | 1,436 | $6.52K | 0.00% | −88−5.7% | ReducedConverted for a 1-for-10 split |
| Morgan Stanley | 1,199 | $5.44K | 0.00% | +48+4.2% | AddedConverted for a 1-for-10 split |
| Spectrum Wealth Counsel, LLC | 503 | $2.28K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Princeton Global Asset Management LLC | 500 | $2.27K | 0.00% | +500 | New |
| Gs Investments, Inc. | 200 | $908 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| JPMorgan Chase & Co | 104 | $472 | 0.00% | +9+9.4% | AddedConverted for a 1-for-10 split |
| Wells Fargo & Company | 61 | $277 | 0.00% | +32+107.5% | AddedConverted for a 1-for-10 split |
| Harbour Investments, Inc. | 50 | $227 | 0.00% | +50 | New |
| GWM Advisors LLC | 14 | $64 | 0.00% | −1−3.4% | ReducedConverted for a 1-for-10 split |
| Qube Research & Technologies Ltd | 6 | $27 | 0.00% | −1−13.0% | ReducedConverted for a 1-for-10 split |
| Royal Bank of Canada | 6 | $0 | 0.00% | −1−11.8% | ReducedConverted for a 1-for-10 split |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −237,408−100.0% | Sold outConverted for a 1-for-10 split |
| First PREMIER Bank | 0 | $0 | 0.00% | −80,754−100.0% | Sold outConverted for a 1-for-10 split |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −8,800−100.0% | Sold outConverted for a 1-for-10 split |
| State Street Corp | 0 | $0 | 0.00% | −8,124−100.0% | Sold outConverted for a 1-for-10 split |
| Mariner, LLC | 0 | $0 | 0.00% | −6,900−100.0% | Sold outConverted for a 1-for-10 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −6,310−100.0% | Sold outConverted for a 1-for-10 split |
| Peapack Gladstone Financial Corp | 0 | $0 | 0.00% | −5,230−100.0% | Sold outConverted for a 1-for-10 split |
| Silver Oak Securities, Inc | 0 | $0 | 0.00% | −5,189−100.0% | Sold outConverted for a 1-for-10 split |
| Creative Planning | 0 | $0 | 0.00% | −4,752−100.0% | Sold outConverted for a 1-for-10 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −4,448−100.0% | Sold outConverted for a 1-for-10 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,672−100.0% | Sold outConverted for a 1-for-10 split |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −1,624−100.0% | Sold outConverted for a 1-for-10 split |
| Nadler Financial Group, Inc. | 0 | $0 | 0.00% | −1,375−100.0% | Sold outConverted for a 1-for-10 split |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −1,282−100.0% | Sold outConverted for a 1-for-10 split |
| 1st Source Bank | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-10 split |
| Baird Financial Group, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-10 split |
| Elgethun Capital Management | 0 | $0 | 0.00% | −544−100.0% | Sold outConverted for a 1-for-10 split |
| LM Advisors LLC | 0 | $0 | 0.00% | −362−100.0% | Sold outConverted for a 1-for-10 split |
| UBS Group AG | 0 | $0 | 0.00% | −50−100.0% | Sold outConverted for a 1-for-10 split |
| FMR LLC | 0 | $0 | 0.00% | −34−100.0% | Sold outConverted for a 1-for-10 split |
| Bank of America Corp | 0 | $0 | 0.00% | −5−100.0% | Sold outConverted for a 1-for-10 split |